Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein. (Q39791955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Caterina Lapenta

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Stefano M. Santini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Paola Di Bonito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Claudia Muratori

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Maurizio Federico

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Felicia Grasso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Stefania Mochi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Linda Petrone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Emanuele Fanales-Belasio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Arianna Mei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Armando Cesolini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Giuseppe Laconi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Heinke Conrad

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Helga Bernhard

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Claudia J Dembek

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Simona Donati

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Colomba Giorgi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

2 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

45-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800648%20AND%20SRC:MED&resulttype=core&format=json

Plasmid DNA and viral vector-based vaccines for the treatment of cancer

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Spontaneous Regression of Grade 3 Vulvar Intraepithelial Neoplasia Associated with Human Papillomavirus-16–Specific CD4+and CD8+T-Cell Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Therapeutic vaccination for HPV induced cervical cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

ADAP is dispensable for NK cell development and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Studies in antibody response of mice to tumour inoculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Virus-like particles: passport to immune recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Recombinant lentivector as a genetic immunization vehicle for antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

DNA vaccines for cervical cancer: from bench to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Use of viral vectors for the development of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Human clinical trials of plasmid DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Mechanisms of human papillomavirus-induced oncogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Neutralization of animal virus infectivity by antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

T-cell immunity generated by recombinant adenovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Elicitation of immunity to HIV type 1 Gag is determined by Gag structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.09.012